Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma

BACKGROUND: The enhancer of zeste homolog 2 (EZH2) gene exerts oncogene-like activities and its (over)expression has been linked to several human malignancies. Here, we studied a possible association between EZH2 expression and prognosis in patients with renal cell carcinoma (RCC). METHODS: EZH2 pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagener, Nina, Macher-Goeppinger, Stephan, Pritsch, Maria, Hüsing, Johannes, Hoppe-Seyler, Karin, Schirmacher, Peter, Pfitzenmaier, Jesco, Haferkamp, Axel, Hoppe-Seyler, Felix, Hohenfellner, Markus
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958940/
https://www.ncbi.nlm.nih.gov/pubmed/20920340
http://dx.doi.org/10.1186/1471-2407-10-524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958940/
https://www.ncbi.nlm.nih.gov/pubmed/20920340
http://dx.doi.org/10.1186/1471-2407-10-524

Ejemplares similares